You searched for "SRM"

757 results found

Prostate cancer and an electronic nose

So far the transrectal ultrasound guided (TRUS) biopsy has been the ‘gold standard’ for diagnosing prostate cancer. However, it is invasive and can lead to complications, so there is a need for new non-invasive diagnostic tools to avoid unnecessary biopsy...

Increased use of active surveillance for men with intermediate risk prostate cancer

The optimal management of men with intermediate risk prostate cancer remains unclear and continues to be debated. The authors interrogate the US National Cancer Database for 176,122 men diagnosed with intermediate risk prostate cancer between 2010 and 2016. Of these...

SWL for renal stones – a new index

Shockwave lithotripsy (SWL) treatment is a common, non-invasive urology procedure used for kidney stones nearly every day throughout the UK. In this study the team evaluated factors affecting treatment success of SWL treatment. The prospective data were collected from 2013...

SNNLive caught up with Andrew Tasker, CEO of Femeda Ltd.

SNNLive spoke with Andrew Tasker, CEO of Femeda Ltd. at the Planet MicroCap Showcase 2019 in Las Vegas, NV, and they discuss the following topics: Overview and history of Femeda, Update since our last interview...

TUF Trials

The Urology Foundation has engaged in a review of its mission and consulted with urology professionals along the way.

Announcing a new specialist distributor of medical devices for prostate cancer

Healthcare Supply Solutions are a new distributor focussed on medical devices for the diagnosis and management of Prostate Cancer.

Bladder Health UK – Patient Support Charity

Since its beginnings as an Interstitial Support Group back in 1994 Bladder Health UK has developed and grown into a well-respected provider of support, expertise and education to both patients and healthcare professionals. The charity's ambition is to continue to...

Submit your abstract for SIU 2025 today!

  Present your innovative research on the world stage! 🌟   Submit your abstract for SIU 2025 Edinburgh by April 3 2025, and be part of shaping the future of urology.    Click the image to access        

SIU 2024 B2B GU Cancers Triad Meeting Proceedings

You can now access the SIU 2024 B2B GU Cancers Triad proceedings, published as a supplement to the February issue of SIUJ. Review the latest updates on bladder, kidney and prostate cancers that were presented by expert faculty. Access the...

NHS Greater Glasgow and Clyde Prostate Cancer Nurse Specialist wins Continence and Urology Nurse of the Year at BJN Awards 2025

Leann McLaughlin, a Uro-Oncology CNS who specialises in prostate cancer at Inverclyde Royal Hospital, NHS Greater Glasgow and Clyde, has won Urology and Continence Nurse of the Year at the British Journal of Nursing (BJN) Awards 2025. The prestigious event...

The value of Urolink: an OOPE experience

I was fortunate enough to be able to take some time out of my training after ST5 to pursue an Out Of Programme Experience (OOPE) year. During the Urolink meeting at the British Association of Urological Surgeons (BAUS) 2017 conference...

Bladder carcinoma MRI

Bladder malignancy is one of the commonest malignancies of the renal tract, accounting for approximately 6% of male malignancy and 2% of female malignancy. The incidence increases with patient age with 70% of patients being over the age of 65...